Samuel R. Saks, Director at Tonix Pharmaceuticals Holding Corp. (TNXP), bought 12,500 shares at $2.00 ($25K) on 2016-06-21, disclosed to the SEC on 2016-06-29.
Open-market purchase of $25k TNXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ASPX | BUY | 2014-02-12 | $26K | — | Filing → |
| JAZZ | BUY | 2007-11-15 | $66K | — | Filing → |
| JAZZ | BUY | 2007-11-14 | $318K | — | Filing → |